Transketolase	transketolase	O	O	O	O
abnormality	abnormality	O	O	O	O
in	in	O	O	O	O
tolazamide-induced	tolazamide-induced	O	O	O	O
Wernicke	wernicke	O	O	OTHERS	I
's	's	O	O	OTHERS	I
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
studied	studied	O	O	O	O
a	a	O	O	O	O
thiamine-dependent	thiamine-dependent	O	O	O	O
enzyme	enzyme	O	O	O	O
,	,	O	O	O	O
transketolase	transketolase	O	O	O	O
,	,	O	O	O	O
from	from	O	O	O	O
fibroblasts	fibroblasts	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
patient	patient	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
Wernicke	wernicke	O	O	OTHERS	I
's	's	O	O	OTHERS	I
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
when	when	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
tolazamide	tolazamide	O	O	OTHERS	I
,	,	O	O	O	O
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
delineate	delineate	O	O	O	O
if	if	O	O	O	O
this	this	O	O	O	O
patient	patient	O	O	O	O
also	also	O	O	O	O
had	had	O	O	O	O
transketolase	transketolase	O	O	O	O
abnormality	abnormality	O	O	O	O
[	[	O	O	O	O
high	high	O	O	O	O
Km	km	O	O	O	O
for	for	O	O	O	O
thiamine	thiamine	CHEMICALS	O	OTHERS	I
pyrophosphate	pyrophosphate	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
TPP	tpp	O	O	OTHERS	I
)	)	O	O	O	O
]	]	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
previously	previously	O	O	O	O
reported	reported	O	O	O	O
in	in	O	O	O	O
postalcoholic	postalcoholic	O	O	O	O
Wernicke-Korsakoff	wernicke-korsakoff	O	O	O	O
syndrome	syndrome	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
to	to	O	O	O	O
this	this	O	O	O	O
patient	patient	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
also	also	O	O	O	O
studied	studied	O	O	O	O
this	this	O	O	O	O
enzyme	enzyme	O	O	O	O
from	from	O	O	O	O
three	three	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
kindreds	kindreds	O	O	O	O
without	without	O	O	O	O
any	any	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
Wernicke	wernicke	O	O	OTHERS	I
's	's	O	O	OTHERS	I
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
and	and	O	O	O	O
from	from	O	O	O	O
four	four	O	O	O	O
normal	normal	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
found	found	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
above-mentioned	above-mentioned	O	O	O	O
patient	patient	O	O	O	O
and	and	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
kindreds	kindreds	O	O	O	O
with	with	O	O	O	O
no	no	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
Wernicke	wernicke	O	O	OTHERS	I
's	's	O	O	OTHERS	I
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
had	had	O	O	O	O
abnormal	abnormal	O	O	O	O
transketolase	transketolase	O	O	O	O
as	as	O	O	O	O
determined	determined	O	O	O	O
by	by	O	O	O	O
its	its	O	O	O	O
Km	km	O	O	O	O
for	for	O	O	O	O
TPP	tpp	O	O	OTHERS	I
.	.	O	O	O	O

These	these	O	O	O	O
data	data	O	O	O	O
suggest	suggest	O	O	O	O
a	a	O	O	O	O
similarity	similarity	O	O	O	O
between	between	O	O	O	O
postalcoholic	postalcoholic	O	O	O	O
Wernicke-Korsakoff	wernicke-korsakoff	O	O	O	O
syndrome	syndrome	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
tolazamide-induced	tolazamide-induced	O	O	O	O
Wernicke	wernicke	O	O	OTHERS	I
's	's	O	O	OTHERS	I
encephalopathy	encephalopathy	O	DISEASE	OTHERS	I
from	from	O	O	O	O
the	the	O	O	O	O
standpoint	standpoint	O	O	O	O
of	of	O	O	O	O
transketolase	transketolase	O	O	O	O
abnormality	abnormality	O	O	O	O
.	.	O	O	O	O

